{"created":"2023-05-15T14:21:17.914571+00:00","id":4347,"links":{},"metadata":{"_buckets":{"deposit":"44f84819-9ded-4d5f-906c-2f431170e159"},"_deposit":{"created_by":12,"id":"4347","owners":[12],"pid":{"revision_id":0,"type":"depid","value":"4347"},"status":"published"},"_oai":{"id":"oai:iwatemed.repo.nii.ac.jp:00004347","sets":["17:78:80","23:35"]},"author_link":["14424","14425"],"item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2014-07","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"7","bibliographicPageEnd":"939","bibliographicPageStart":"933","bibliographicVolumeNumber":"63","bibliographic_titles":[{"bibliographic_title":"産婦人科の実際"}]}]},"item_10001_heading_23":{"attribute_name":"見出し","attribute_value_mlt":[{"subitem_heading_banner_headline":"医学部","subitem_heading_headline":"産婦人科学","subitem_heading_language":"ja"}]},"item_10001_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0558-4728","subitem_source_identifier_type":"ISSN"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"利部, 正裕"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"杉山, 徹"}],"nameIdentifiers":[{}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"【卵巣がん治療の個別化を目指す新たな局面】 分子標的治療薬の役割　Bevacizumabへの期待","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"【卵巣がん治療の個別化を目指す新たな局面】 分子標的治療薬の役割　Bevacizumabへの期待"}]},"item_type_id":"10001","owner":"12","path":["35","80"],"pubdate":{"attribute_name":"公開日","attribute_value":"2014-12-25"},"publish_date":"2014-12-25","publish_status":"0","recid":"4347","relation_version_is_last":true,"title":["【卵巣がん治療の個別化を目指す新たな局面】 分子標的治療薬の役割　Bevacizumabへの期待"],"weko_creator_id":"12","weko_shared_id":12},"updated":"2023-05-15T18:01:50.400615+00:00"}